Advertisement

Formulary Management Strategies

This resource provides practical articles on Cost Management Strategies and links to locate them. These articles are provided to assist pharmacy managers and directors in dealing with the management issues focused on the affordability and accessibility of pharmaceuticals. Current topics covered in this new resource section include pharmacists' intervention strategies, formulary management strategies, population-based strategies, and anti-infective management strategies. Additional strategies will be added periodically to assist managers and directors in managing high-cost issues in pharmacy.

  1. Curtiss FR. Formulary management methods and pharmacoeconomics. J Manag Care Pharm. 2003 Sep-Oct;9(5):452-3, 455-6.
    [No abstract available.]
  2. Lucarelli CD. Formulary management strategies for type 3 serotonin receptor antagonists. Am J Health Syst Pharm. 2003; 60 (Suppl 1): S4-11.
  3. Tan EL, Day RO, Brien JA. Improving decision outcomes of drug and therapeutics committees. J Pharm Pract and Res; 2003; 33(1): 65-67.
    [No abstract available.]
  4. Odedina FT, Sullivan J, Nash R, Clemmons CD. Use of pharmacoeconomic data in making hospital formulary decisions. Am J Health Syst Pharm. 2002; 59: 1441-1444.
  5. Grace KA, Swiecki J, Hyatt R, Gibbs H, Jones DL, et.al. Implementation of therapeutic-interchange clinic of HMG-CoA reductase inhibitors. Am J Health Syst Pharm. 2002; 59: 1077-82.
  6. Whalen CR, Watson TL, Baize T, Ball A. Formulary management of colony-stimulating factors. Am J Health Syst Pharm. 2002; 59(Suppl 2): S21-27.
  7. Schachtner JM, Guharoy R, Medicis JJ, Newman N, Speizer R. Prevalence and cost savings of therapeutic interchange among U.S. hospitals. Am J Health Syst Pharm. 2002; 59:529-33.
  8. Halley HJ. Approaches to drug therapy, formulary and pathway management in a large community hospital. Am J Health Syst Pharm. 2000; 57(Suppl 3); S17-21.
  9. Byrne MF, Murray FE. Formulary management of proton pump inhibitors. Pharmacoeconomics. 1999 Sep; 16(3): 225-46.
  10. Beis SJ, Anandan JV. Formulary management in an integrated health care system. Pharm Pract Manag Q. 1999 Jan; 18(4): 43-49.
    [No abstract available.]
  11. Hedayati S, Kleinstiver PW. Predictive cost analysis model for estimating formulary impact of new products on managed care. J Manage Care Pharm. 1998; 4(Nov-Dec); 585-590.
    [No abstract available.]
  12. Bailey M, Ferro K. Innovative drug formulary management through computer-assisted protocols. J Manage Care Pharm. 1998; 4(May-Jun);246-47; 250-52.
    [No abstract available.]
  13. Jarry PD, Fish L. Insights on outpatient formulary management in a vertically integrated health care system. Formulary. 1997; 32(May); 500-502, 513-514.
    [No abstract available]
  14. Mutnick AH, Ross MB. Formulary management at a tertiary care teaching hospital. Pharm Pract Manage Q. 1997; 17(1); 63-86.
    [No abstract available.]
  15. Gerbrandt KR, Yedinak KC. Formulary management of ACE inhibitors. PharmacoEcon. 1996; 10(Dec); 594-613.
  16. Massoomi F. Formulary management: Antibiotics and therapeutic interchange. Pharm Prac Manage Q. 1996; 16(3): 11-18.
  17. Ritchie DJ. Cost and quality considerations in antibiotic formulary management. Pharm Prac Manage Q. 1996; 16(2): 4-8.
    [No abstract available.]

 
Advertisement